U.S. Food and Drug Administration (USFDA) has completed inspection of J.B. Chemicals & Pharmaceuticals’ formulations manufacturing facility- T20 located at Plot No. 4, GIDC, Panoli, Gujarat. The inspection was conducted from March 3, 2025 to March 7, 2025. The said audit has been successfully completed by the USFDA with ‘No Observations’ and thus NO Form 483 was issued.
The company remains committed to producing quality products, embedding a quality culture across the organization and continuously investing in systems, processes & training of its employees so that it can maintain the highest standards of quality and compliance for all its markets.
J. B. Chemicals & Pharmaceuticals is engaged in the business of manufacturing and marketing of diverse range of pharmaceutical formulations, herbal remedies and APIs.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1681.00 |
| Dr. Reddys Lab | 1217.60 |
| Cipla | 1224.60 |
| Zydus Lifesciences | 935.50 |
| Lupin | 2349.75 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: